文献速递慢性肾脏病血液净化与透析

癫痫发作、抗癫痫药物与慢性肾脏病

Seizures, Antiepileptic Drugs, and CKD.
PubMed 文献 · Am J Kidney Dis · 2018-05-18

本文综述了慢性肾脏病(CKD)患者中癫痫发作的两大类情况:CKD背景下出现的急性症状性癫痫发作,以及癫痫患者后续发展为CKD。文章讨论了尿毒症癫痫发作的病理生理、管理方法,以及抗癫痫药物(AEDs)在CKD患者中的药代动力学特点与使用策略,尤其关注血液透析患者。

要点

  • 肾衰竭患者尿毒症性癫痫发作发生率约10%,常为非惊厥性,易与尿毒症脑病混淆。
  • CKD患者AEDs选择、负荷、滴定和维持需考虑药代动力学改变。
  • 血液透析患者的AEDs管理需特别关注。

核心结论

  • CKD患者癫痫发作管理需区分急性症状性发作与癫痫,并个体化调整AEDs。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • 肾衰竭患者尿毒症性癫痫发作发生率约10%。
  • 尿毒症性癫痫发作常为非惊厥性,可模拟尿毒症脑病。
  • CKD患者AEDs药代动力学可能改变,影响选择、负荷、滴定和维持。

临床怎么用

  • 非神经科医生需识别尿毒症性癫痫发作,注意其非惊厥性表现。
  • CKD患者使用AEDs时应考虑药代动力学变化,调整剂量。
  • 血液透析患者需特别关注AEDs的管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There are 2 major categories of patients with seizures and chronic kidney disease (CKD): patients who develop acute symptomatic seizures in the setting of CKD and patients with epilepsy who at some point develop CKD. The incidence of uremic seizures with kidney failure is ∼10%. These seizures are often nonconvulsive and may mimic uremic encephalopathy. Recognition and management of such situations may be challenging for treating physicians who are non-neurologists. Furthermore, practitioners caring for patients with seizures with or without an established diagnosis of epilepsy in the setting of CKD frequently encounter challenges in the selection, loading, titration, and maintenance of antiepileptic drugs (AEDs) due to potentially altered pharmacokinetics of the AEDs. We review the pathophysiology of uremia, uremic seizures, and other neurologic complications of kidney failure; management approaches to the treatment of such complications; the relevant mechanisms of action and pharmacokinetics of AEDs with their use in CKD; and in particular, the management of AEDs in patients requiring hemodialysis therapy.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Títoff V, Moury HN, Títoff IB, et al. Seizures, Antiepileptic Drugs, and CKD. Am J Kidney Dis. 2018. PMID: 29784616. doi:10.1053/j.ajkd.2018.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。